Prelude Therapeutics
PRLD
#9034
Rank
A$0.10 B
Marketcap
$1.91
Share price
5.83%
Change (1 day)
-57.74%
Change (1 year)

Prelude Therapeutics (PRLD) - Cash on Hand

Cash on Hand as of June 2024 : A$0.27 Billion

According to Prelude Therapeutics's latest financial reports the company has A$0.27 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Prelude Therapeutics - Cash on Hand chart (from 2019 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31A$0.34 B15.33%
2022-12-31A$0.29 B-26.21%
2021-12-31A$0.40 B41.49%
2020-12-31A$0.28 B952.91%
2019-12-31A$26.96 M21.81%
2018-12-31A$22.13 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$0.43 B 59.25%๐Ÿ‡บ๐Ÿ‡ธ USA